Fasting conditions in clinical oncology trials and drug labelling - Authors' reply.
Saved in:
| Title: | Fasting conditions in clinical oncology trials and drug labelling - Authors' reply. |
|---|---|
| Authors: | Lubberman FJE; Department of Pharmacy, Radboud University Medical Center, Nijmegen 6500 HB, Netherlands. Electronic address: floor.lubberman@radboudumc.nl., Burger D; Department of Pharmacy, Radboud University Medical Center, Nijmegen 6500 HB, Netherlands., van Erp NP; Department of Pharmacy, Radboud University Medical Center, Nijmegen 6500 HB, Netherlands. |
| Source: | The Lancet. Oncology [Lancet Oncol] 2017 Sep; Vol. 18 (9), pp. e507. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1474-5488 |
|---|---|
| DOI: | 10.1016/S1470-2045(17)30599-5 |
